| 000 | 01773 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250514030603.0 | ||
| 264 | 0 | _c20021001 | |
| 008 | 200210s 0 0 eng d | ||
| 022 | _a1098-8823 | ||
| 024 | 7 |
_a10.1016/s0090-6980(01)00185-x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aChen, Nannan | |
| 245 | 0 | 0 |
_aSelective inhibition of COX-2 is beneficial to mice infected intranasally with VSV. _h[electronic resource] |
| 260 |
_bProstaglandins & other lipid mediators _cFeb 2002 |
||
| 300 |
_a143-55 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aArachidonate 5-Lipoxygenase _xmetabolism |
| 650 | 0 | 4 | _aBlotting, Western |
| 650 | 0 | 4 | _aCelecoxib |
| 650 | 0 | 4 |
_aCentral Nervous System _xdrug effects |
| 650 | 0 | 4 | _aCyclooxygenase 1 |
| 650 | 0 | 4 | _aCyclooxygenase 2 |
| 650 | 0 | 4 |
_aInterferon-gamma _xmetabolism |
| 650 | 0 | 4 |
_aInterleukin-12 _xmetabolism |
| 650 | 0 | 4 |
_aIsoenzymes _xantagonists & inhibitors |
| 650 | 0 | 4 | _aMembrane Proteins |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 |
_aNeutrophils _xdrug effects |
| 650 | 0 | 4 |
_aNitric Oxide Synthase _xmetabolism |
| 650 | 0 | 4 |
_aProstaglandin-Endoperoxide Synthases _xmetabolism |
| 650 | 0 | 4 |
_aPyrazoles _xpharmacology |
| 650 | 0 | 4 | _aReverse Transcriptase Polymerase Chain Reaction |
| 650 | 0 | 4 |
_aRhabdoviridae Infections _xdrug therapy |
| 650 | 0 | 4 |
_aSulfonamides _xpharmacology |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 |
_aVesicular stomatitis Indiana virus _xdrug effects |
| 700 | 1 | _aRestivo, Andrew | |
| 700 | 1 | _aReiss, Carol Shoshkes | |
| 773 | 0 |
_tProstaglandins & other lipid mediators _gvol. 67 _gno. 2 _gp. 143-55 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0090-6980(01)00185-x _zAvailable from publisher's website |
| 999 |
_c11840642 _d11840642 |
||